Anne O’Neill

Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion

Arnold H. Zea, Paulo C. Rodrı́guez, Michael B. Atkins et al. · Cancer Research · 2005 · 833 citations

Medicine, Immunology, Oncology +17

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

Robert I. Haddad, Anne O’Neill, Guilherme Rabinowits et al. · The Lancet Oncology · 2013 · 747 citations

Medicine, Oncology, Radiation Oncology +14

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI

Olivia Pagani, Anne O’Neill, M. Castiglione et al. · European Journal of Cancer · 1998 · 227 citations

Medicine, Oncology, Pharmacology +14

Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188)

Nancy E. Davidson, Anne O’Neill, Allen M. Vukov et al. · Journal of Clinical Oncology · 2005 · 226 citations

Medicine, Endocrinology, Oncology +14

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer

Joseph A. Sparano, Anne O’Neill, Katherine Alpaugh et al. · JAMA Oncology · 2018 · 199 citations · Full text

Medicine, Oncology, Pharmacotherapy +16